Gurlek, Feridun, and Eyyüp Tasdemir. “Is It an Advantage or Disadvantage to Usage Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in COVID-19 Patients?”. International Journal of Research in Medical Sciences 8, no. 12 (November 27, 2020): 4200–4205. Accessed October 14, 2025. https://www.msjonline.org/index.php/ijrms/article/view/8883.